Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents

• Egile Nagusiak: Erin M. Paradis (Egilea), Oleg Tikhonov (Egilea), Xin Cao (Egilea), Susanna M. Kharit (Egilea), Aleksandr Fokin (Egilea), Heather L. Platt (Egilea), Frederick Wittke (Egilea), Veronika Jotterand (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2021-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Varicella (chickenpox) is a common, highly contagious disease caused by primary infection with varicella zoster virus (VZV), which can result in bacterial superinfection, central nervous system complications, and hospitalization. Stage 2 of this Phase 3 open-label study (ClinicalTrials.gov identifie...